product < production < productions

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by production

Number of relevant bibliographic references: 380.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000163 (2020)	Tavis K. Anderson [États-Unis] ; Jennifer Chang [États-Unis] ; Zebulun W. Arendsee [États-Unis] ; Divya Venkatesh [Royaume-Uni] ; Carine K. Souza [États-Unis] ; J Brian Kimble [États-Unis] ; Nicola S. Lewis [Royaume-Uni] ; C Todd Davis [États-Unis] ; Amy L. Vincent [États-Unis]	Swine Influenza A Viruses and the Tangled Relationship with Humans.
000183 (2020)	Dhanya Dharmapalan	Influenza
000296 (2019)	Chia-Chun Lai [Taïwan] ; Yu-Chieh Cheng [Taïwan] ; Pin-Wen Chen [Taïwan] ; Ting-Hui Lin [Taïwan] ; Tsai-Teng Tzeng [Taïwan] ; Chia-Chun Lu [Taïwan] ; Min-Shi Lee [Taïwan] ; Alan Yung-Chih Hu [Taïwan]	Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
000350 (2019)	Chia-Chun Lai [Taïwan] ; Tsai-Chuan Weng [Taïwan] ; Yu-Fen Tseng [Taïwan] ; Jen-Ron Chiang [Taïwan] ; Min-Shi Lee [Taïwan] ; Alan Yung-Chih Hu [Taïwan]	Evaluation of novel disposable bioreactors on pandemic influenza virus production
000370 (2019)	Eun-Hye Bae [Corée du Sud] ; Sang Hwan Seo [Corée du Sud] ; Chang-Ung Kim [Corée du Sud] ; Min Seong Jang [Corée du Sud] ; Min-Suk Song [Corée du Sud] ; Tae-Young Lee [Corée du Sud] ; Yu-Jin Jeong [Corée du Sud] ; Moo-Seung Lee [Corée du Sud] ; Jong-Hwan Park [Corée du Sud] ; Pureum Lee [Corée du Sud] ; Young Sang Kim [Corée du Sud] ; Sang-Hyun Kim [Corée du Sud] ; Doo-Jin Kim [Corée du Sud]	Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages
000384 (2019)	Punnee Pitisuttithum [Thaïlande] ; Ponthip Wirachwong [Thaïlande]	A review of epidemic preparedness for influenza through local vaccine production: national security for Thailand
000450 (2018)	Rose T. Byrne-Nash ; David F. Miller ; Katie M. Bueter ; Jacob H. Gillis ; Laura R. Kuck ; Kathy L. Rowlen	VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
000495 (2018)	Debbie C. P. Lee ; Neil Q. Tay ; Marini Thian ; Nayana Prabhu ; Kazuki Furuhashi ; David M. Kemeny	Prior exposure to inhaled allergen enhances anti-viral immunity and T cell priming by dendritic cells
000514 (2018)	Emma Petiot [France] ; Anaïs Proust [France] ; Aurélien Traversier [France] ; Laurent Durous [France] ; Frédéric Dappozze [France] ; Marianne Gras [France] ; Chantal Guillard [France] ; Jean-Marc Balloul [France] ; Manuel Rosa-Calatrava [France]	Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
000527 (2018)	Eun-Ha Kim [Corée du Sud] ; Hyeok-Il Kwon [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; Young-Il Kim [Corée du Sud] ; Young-Jae Si [Corée du Sud] ; In-Won Lee [Corée du Sud] ; Se Mi Kim [Corée du Sud] ; Soo-In Kim [Corée du Sud] ; Dong-Ho Ahn [Corée du Sud] ; Young Ki Choi [Corée du Sud]	Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
000565 (2018)	David Champredon ; Marek Laskowski ; Nathalie Charland [Canada] ; Seyed M. Moghadas	Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada
000639 (2017)	Pei-Feng Liu [États-Unis] ; Yanhan Wang [États-Unis] ; Yu-Tsueng Liu [États-Unis] ; Chun-Ming Huang [États-Unis]	Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus
000648 (2017)	Irina Isakova-Sivak [Russie] ; Larisa Rudenko [Russie]	Tackling a novel lethal virus: a focus on H7N9 vaccine development.
000716 (2017)	Ilaria Manini ; Claudia Maria Trombetta ; Giacomo Lazzeri ; Teresa Pozzi ; Stefania Rossi ; Emanuele Montomoli [Italie]	Egg-Independent Influenza Vaccines and Vaccine Candidates
000745 (2017)	Ernest Milián [Canada] ; Thomas Julien [France] ; Rafael Biaggio [Canada] ; Alina Venereo-Sanchez [Canada] ; Johnny Montes [Canada] ; Aziza P. Manceur [Canada] ; Sven Ansorge [Canada] ; Emma Petiot [France] ; Manuel Rosa-Calatrava [France] ; Amine Kamen [Canada]	Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics.
000830 (2016)	Scott Preiss [Belgique] ; Nathalie Garçon [France] ; Anthony L. Cunningham [Australie] ; Richard Strugnell [Australie] ; Leonard R. Friedland [États-Unis]	Vaccine provision: Delivering sustained & widespread use.
000853 (2016)	Erin Sparrow [Suisse, Australie] ; Martin Friede [Suisse] ; Mohamud Sheikh [Australie] ; Siranda Torvaldsen [Australie] ; Anthony T. Newall [Australie]	Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
000867 (2016)	Adeline Kerviel [France] ; Shantoshini Dash [France] ; Olivier Moncorgé [France] ; Baptiste Panthu [France] ; Jan Prchal [France] ; Didier Décimo [France] ; Théophile Ohlmann [France] ; Bruno Lina [France] ; Cyril Favard [France] ; Etienne Decroly [France] ; Michèle Ottmann [France] ; Philippe Roingeard [France] ; Delphine Muriaux [France]	Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus
000872 (2016)	Germain J P. Fernando [Australie] ; Jin Zhang [Australie] ; Hwee-Ing Ng [Australie] ; Oscar L. Haigh [Australie] ; Sally R. Yukiko [Australie] ; Mark A F. Kendall [Australie]	Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
000880 (2016)	Yong-Dae Gwon [Corée du Sud] ; Sehyun Kim [Corée du Sud] ; Yeondong Cho [Corée du Sud] ; Yoonki Heo [Corée du Sud] ; Hansam Cho [Corée du Sud] ; Kihoon Park [Corée du Sud] ; Hee-Jung Lee [Corée du Sud] ; Jiwon Choi [Corée du Sud] ; Haryoung Poo [Corée du Sud] ; Young Bong Kim [Corée du Sud]	Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1
000884 (2016)	Xenia Wörmann [Allemagne] ; Markus Lesch [Allemagne] ; Robert-William Welke [Allemagne] ; Konstantin Okonechnikov [Allemagne] ; Mirshat Abdurishid [Allemagne] ; Christian Sieben [Allemagne] ; Andreas Geissner [Allemagne] ; Volker Brinkmann [Allemagne] ; Markus Kastner [Autriche] ; Andreas Karner [Autriche] ; Rong Zhu [Autriche] ; Peter Hinterdorfer [Autriche] ; Chakkumkal Anish [Allemagne] ; Peter H. Seeberger [Allemagne] ; Andreas Herrmann [Allemagne] ; Thomas F. Meyer [Allemagne] ; Alexander Karlas [Allemagne]	Genetic characterization of an adapted pandemic 2009 H1N1 influenza virus that reveals improved replication rates in human lung epithelial cells.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "production" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "production" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    production
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021